Quadrature Capital Ltd Has $643,000 Position in Doximity, Inc. (NASDAQ:DOCS)

Quadrature Capital Ltd lowered its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 61.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,755 shares of the company's stock after selling 23,530 shares during the quarter. Quadrature Capital Ltd's holdings in Doximity were worth $643,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC lifted its position in shares of Doximity by 29.6% during the 2nd quarter. SG Americas Securities LLC now owns 16,033 shares of the company's stock valued at $448,000 after acquiring an additional 3,659 shares during the last quarter. Blue Trust Inc. raised its position in shares of Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock worth $37,000 after purchasing an additional 1,193 shares during the period. Nisa Investment Advisors LLC lifted its holdings in shares of Doximity by 15,714.3% during the second quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company's stock valued at $310,000 after purchasing an additional 11,000 shares during the last quarter. First Horizon Advisors Inc. boosted its position in shares of Doximity by 80.0% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company's stock valued at $48,000 after purchasing an additional 760 shares during the period. Finally, Fifth Third Bancorp increased its stake in Doximity by 181.6% in the 2nd quarter. Fifth Third Bancorp now owns 3,207 shares of the company's stock worth $90,000 after purchasing an additional 2,068 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Price Performance

NASDAQ:DOCS traded down $1.70 during trading hours on Monday, reaching $53.83. The company's stock had a trading volume of 1,631,748 shares, compared to its average volume of 1,754,395. The company has a market cap of $10.05 billion, a price-to-earnings ratio of 61.02, a price-to-earnings-growth ratio of 4.45 and a beta of 1.39. Doximity, Inc. has a one year low of $22.96 and a one year high of $61.75. The business's 50-day moving average is $47.11 and its 200-day moving average is $37.13.

Analyst Upgrades and Downgrades

A number of analysts have commented on DOCS shares. Truist Financial upped their price objective on shares of Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a research note on Thursday, November 14th. Barclays upped their price target on shares of Doximity from $52.00 to $75.00 and gave the company an "overweight" rating in a research report on Monday, November 11th. Evercore ISI raised their price objective on shares of Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. boosted their target price on shares of Doximity from $30.00 to $48.00 and gave the company a "neutral" rating in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group started coverage on Doximity in a research report on Friday, November 15th. They issued a "neutral" rating and a $58.00 target price for the company. Twelve investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $52.44.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.